Drug Candidate, CQ-001 (cannabidiol “CBD” + IP system), also demonstrated considerably diminished seizures at better doses, with fewer CBD, in comparison to typical CBD. TORONTO, ON / ACCESSWIRE / December 8, 2022 / CANAQUEST Clinical CORP (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a scientific-phase daily life sciences company focused on drug discovery and progress of […]
significant
Study finds significant evidence for inaccurate and misleading labeling of CBD content
In a new review, Johns Hopkins Medication researchers examined a lot more than 100 topical cannabidiol (CBD) products accessible on the internet and at retail retailers, and located sizeable evidence of inaccurate and misleading labeling of CBD material. The analyze also exposed that some of these nonprescription products and solutions contained amounts of delta-9-tetrahydrocannabinol (THC), […]